Sector ratings Novo Nordisk A/S

Equities

Market Closed - Nasdaq Copenhagen Other stock markets 16:20:00 18/11/2025 GMT			5-day change	1st Jan Change
304.85 ^DKK	-2.51%		-2.81%	-51.16%

11-18	NOVO NORDISK : Gets a Neutral rating from UBS	ZD
11-18	SEB Sweden Equity Fund rose 3.7 percent in October – participated in the IPO of Verisure	FW

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Capi.($)	Investor	ESG MSCI	Fundamentals	Financial revisions	Global Valuation	Visibility	Consensus
NOVO NORDISK A/S	216B		A
ELI LILLY AND COMPANY	915B		A
JOHNSON & JOHNSON	481B		BBB
ABBVIE INC.	414B		AA
ROCHE HOLDING AG	310B		AA
ASTRAZENECA PLC	278B		A
NOVARTIS AG	255B		AAA
MERCK & CO., INC.	230B		A
AMGEN INC.	184B		A
GILEAD SCIENCES, INC.	154B		AAA
PFIZER INC.	143B		BBB
SANOFI	127B		A
VERTEX PHARMACEUTICALS INCORPORATED	110B		AA
BRISTOL-MYERS SQUIBB COMPANY	95.29B		A
GSK PLC	95.24B		AA
CHUGAI PHARMACEUTICAL CO., LTD.	90.2B		AA
ALLERGAN PLC	63.66B	-	-	-	-	-	-	-
ALNYLAM PHARMACEUTICALS, INC.	60.84B		AA	-
JIANGSU HENGRUI PHARMACEUTICALS CO.,LTD	57.72B		AA
TAKEDA PHARMACEUTICAL COMPANY LIMITED	44.51B		AA
Average	216.14B		AA
Weighted average by Cap.			AA